Welcome to 4SC
Planegg-Martinsried,

4SC AG develops new drug candidates for the treatment of patients suffering from diseases with high medical needs.
More....

Since 15 December 2005 4SC AG has been listed in the Prime Standard Segment (regulated market) of the Frankfurt Stock Exchange. More....

 

 

News

3 March 2010
4SC to Present at the Credit Suisse Global Healthcare One-on-One Conference and the Kempen & Co Life Sciences Conference

11 February 2010
4SC Announces Treatment of First Patient in a Phase I Study of 4SC-205

4 February 2010
4SC to Present at the 12th Annual Bio CEO and Investor Conference

21 January 2010
4SC Announces Start of Dosing in First-in-Man Phase I Study with 4SC-203

Mailing List

Are you interested in
receiving our news
regularly?
Please click here...

Corporate Video

To view our actual corporate video
please click here....

(The video is available in Geman only.You'll need Real Player in order to view it. Filesize is approx. 20MB)